Alpha Healthcare Acquisition Corp. (AHAC)
| Market Cap | 137.29M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 10.36M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 16 |
| Last Price | $10.34 |
| Previous Close | $10.39 |
| Change ($) | -0.05 |
| Change (%) | -0.48% |
| Day's Open | 10.43 |
| Day's Range | 10.32 - 10.45 |
| Day's Volume | 23,822 |
| 52-Week Range | 9.65 - 16.96 |
Humacyte is set to go public via the special purpose acquisition company Alpha Healthcare Acquisition Corp (NASDAQ: AHAC) in a deal that values the company at around $800 million. Humacyte founder and ...
NEW YORK, March 27, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class A...
They could even deliver greater gains than just a 10-times return.
DURHAM, N.C., March 11, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today ...
The biotech is going public through the special acquisition company (SPAC).
DURHAM, N.C., March 05, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today ...
Why Humacyte Is Going Public Via SPAC
Feb.17 -- Dr. Laura Niklason, chief executive officer and founder of Humacyte, discusses the biotech company's decision to go public through a merger with Alpha Healthcare Acquisition Corp., a special p...
Humacyte is a leader in regenerative medicine, growing human tissue in the lab that can be transplanted into any patient.
NEW YORK and DURHAM, N.C., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC) (“AHAC”), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced ex...
NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Alpha Healthcare Acquisition Corp. (the “Company”) announced today that holders of the units sold in the Company's initial public offering of 10,000,000 units...
New York, NY, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Alpha Healthcare Acquisition Corp. (NASDAQ: AHACU) (the “Company”) announced today that it closed its initial public offering of 10,000,000 units at a ...
New York, NY, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Alpha Healthcare Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of 10,000,000 units at $10.00 per unit. T...
About AHAC
Alpha Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
| Industry Shell Companies | IPO Date Sep 18, 2020 |
| Stock Exchange NASDAQ | Ticker Symbol AHAC |